Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyung-Hun Lee

Showing results (221-230 of 248) with videos related to

Pageof 25
Sort By:
JAMA Oncology|April 2, 2026
Clonal Hematopoiesis and Risk of Trastuzumab-Related Cardiotoxic EffectsChan Soon Park, Gangpyo Ryu, Hyo-Jeong Ahn, et al.
Acta Haematologica|December 5, 2012
RANTES polymorphisms and the risk of graft-versus-host disease in human leukocyte antigen-matched sibling allogeneic hematopoietic stem cell transplantationDong-Yeop Shin, Inho Kim, Jin Hee Kim, et al.
European Journal of Cancer (Oxford, England : 1990)|December 17, 2023
Pemetrexed plus vinorelbine versus vinorelbine monotherapy in patients with metastatic breast cancer (KCSG-BR15-17): A randomized, open-label, multicenter, phase II trialDae-Won Lee, Kyung Hae Jung, Kyung-Hun Lee, et al.
Plos One|May 24, 2013
Targeted sequencing of cancer-related genes in colorectal cancer using next-generation sequencingSae-Won Han, Hwang-Phill Kim, Jong-Yeon Shin, et al.
Clinical Transplantation|November 1, 2011
Impact of vitamin D receptor gene polymorphisms on clinical outcomes of HLA-matched sibling hematopoietic stem cell transplantationHyeon Jin Cho, Dong-Yeop Shin, Jin Hee Kim, et al.
European Journal of Cancer (Oxford, England : 1990)|November 4, 2017
Phase II, multicentre, randomised trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine as first-line chemotherapy in patients with HER2-negative metastatic breast cancerYeon Hee Park, Seock-Ah Im, Sung-Bae Kim, et al.
Cancer Research and Treatment|November 18, 2022
A Phase II Trial of S-1 and Oxaliplatin in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane (KCSG-BR07-03)Dae-Won Lee, Bhumsuk Keam, Keun Seok Lee, et al.
Journal for Immunotherapy of Cancer|June 17, 2020
Phase IA/IB study of single-agent tislelizumab, an investigational anti-PD-1 antibody, in solid tumorsJayesh Desai, Sanjeev Deva, Jong Seok Lee, et al.
Cancer Communications (London, England)|May 30, 2019
Quality of life outcomes including neuropathy-associated scale from a phase II, multicenter, randomized trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine as first-line chemotherapy for HER2-negative metastatic breast cancer: Korean Cancer Study Group Trial (KCSG BR13-11)Ji-Yeon Kim, Seri Park, Seock-Ah Im, et al.
Annals of Surgery|February 21, 2018
Oncological Benefits of Neoadjuvant Chemoradiation With Gemcitabine Versus Upfront Surgery in Patients With Borderline Resectable Pancreatic Cancer: A Prospective, Randomized, Open-label, Multicenter Phase 2/3 TrialJin-Young Jang, Youngmin Han, Hongeun Lee, et al.
Pageof 25

Showing results (221-230 of 248) with videos related to

Sort By:
Pageof 25
JAMA Oncology|April 2, 2026
Clonal Hematopoiesis and Risk of Trastuzumab-Related Cardiotoxic EffectsChan Soon Park, Gangpyo Ryu, Hyo-Jeong Ahn, et al.
Acta Haematologica|December 5, 2012
RANTES polymorphisms and the risk of graft-versus-host disease in human leukocyte antigen-matched sibling allogeneic hematopoietic stem cell transplantationDong-Yeop Shin, Inho Kim, Jin Hee Kim, et al.
European Journal of Cancer (Oxford, England : 1990)|December 17, 2023
Pemetrexed plus vinorelbine versus vinorelbine monotherapy in patients with metastatic breast cancer (KCSG-BR15-17): A randomized, open-label, multicenter, phase II trialDae-Won Lee, Kyung Hae Jung, Kyung-Hun Lee, et al.
Plos One|May 24, 2013
Targeted sequencing of cancer-related genes in colorectal cancer using next-generation sequencingSae-Won Han, Hwang-Phill Kim, Jong-Yeon Shin, et al.
Clinical Transplantation|November 1, 2011
Impact of vitamin D receptor gene polymorphisms on clinical outcomes of HLA-matched sibling hematopoietic stem cell transplantationHyeon Jin Cho, Dong-Yeop Shin, Jin Hee Kim, et al.
European Journal of Cancer (Oxford, England : 1990)|November 4, 2017
Phase II, multicentre, randomised trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine as first-line chemotherapy in patients with HER2-negative metastatic breast cancerYeon Hee Park, Seock-Ah Im, Sung-Bae Kim, et al.
Cancer Research and Treatment|November 18, 2022
A Phase II Trial of S-1 and Oxaliplatin in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane (KCSG-BR07-03)Dae-Won Lee, Bhumsuk Keam, Keun Seok Lee, et al.
Journal for Immunotherapy of Cancer|June 17, 2020
Phase IA/IB study of single-agent tislelizumab, an investigational anti-PD-1 antibody, in solid tumorsJayesh Desai, Sanjeev Deva, Jong Seok Lee, et al.
Cancer Communications (London, England)|May 30, 2019
Quality of life outcomes including neuropathy-associated scale from a phase II, multicenter, randomized trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine as first-line chemotherapy for HER2-negative metastatic breast cancer: Korean Cancer Study Group Trial (KCSG BR13-11)Ji-Yeon Kim, Seri Park, Seock-Ah Im, et al.
Annals of Surgery|February 21, 2018
Oncological Benefits of Neoadjuvant Chemoradiation With Gemcitabine Versus Upfront Surgery in Patients With Borderline Resectable Pancreatic Cancer: A Prospective, Randomized, Open-label, Multicenter Phase 2/3 TrialJin-Young Jang, Youngmin Han, Hongeun Lee, et al.
Pageof 25